Year-end Sale % OFF 
Abstract
Ethanolic extract of 400 mg/kg b.wt, Euphorbia neriifolia Linn. was administered orally to Wistar albino rats of both sexes. Glibenclamide 2.5 mg/kg was used as a standard drug to compare extract potency. Body weight, Oral Glucose Tolerance Taste (OGTT), serum lipid profile, fasting blood glucose (FBG), hepatic glycogen, serum insulin, and glycated hemoglobin were evaluated. In OGTT, the decline in fasting blood glucose content occurred 60 minutes after administration of the extract. Euphorbia neriifolia ethanolic extract (ENEE) produced a significant dose-dependent decrease in FBG. After the end of the treatment, the 15th-day dose of ENEE is 400 mg/kg. After two weeks, the animals were given established repeated oral administration of the ENEE at FBG levels, and after 21 days, ENEE produced a dose-dependent decrease in body weight, FBG, triglycerides, total cholesterol, LDL, VLDL; there was a significant increase in HDL content and liver glycogen as a standard drug glibenclamide 2.5 mg/kg was used to compare the potency of the extract. In OGTT reduction, FBG levels were observed after sixty minutes of extract administration. After treatment, The data concluded that ENEE showed dose-dependent anti-diabetic potential and a potent antihyperlipidemic effect.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Future Journal of Pharmaceuticals and Health Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
